A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer

British Journal of Dermatology

Volumn 161, Issue 5, 2009, Pages 1067-1071

  Prior, S L ^a   Griffiths, A P ^b   Lewis, P D ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Biomarker; D loop; MtDNA; Mutation; Nonmelanoma skin cancer; P53

Indexed keywords

MITOCHONDRIAL DNA; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MUTAGENESIS; NONMELANOMA SKIN CANCER; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CANCER;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DNA, MITOCHONDRIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SKIN DISEASES; SKIN NEOPLASMS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71949112709     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09304.x     Document Type: Article

References (41)

1. Otley CC. Non-melanoma skin cancer: past, present, and future. Curr Probl Dermatol 2001 13 : 109 113.
2. Nishigori C. UV-induced DNA damage in carcinogenesis and its repair. J Dermatol Sci 2000 23 : S41 4.
3. You YH, Lee DH, Yoon JH et al. Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J Biol Chem 2001 276 : 44688 44694.
4. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000 408 : 307 310.
5. Levine AJ. Tumour suppressor genes. Annu Rev Biochem 1993 62 : 623 651.
6. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997 88 : 323 331.
7. Achanta G, Sasaki R, Feng L et al. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ. EMBO J 2005 24 : 3482 3492.
8. Casson P. Basal cell carcinoma. Clin Plast Surg 1980 7 : 301 311.
9. Wikonkal NM, Berg RJW, van Haselen CW et al. Bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers. Arch Dermatol 1997 133 : 599 602.
10. Harvey RA, Chaglassian T, Knapper W, Goulian D. Squamous cell carcinoma of the skin in adolescence. Report of a case. JAMA 1977 238 : 513.
11. Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 1998 37 : 677 681.
12. McGillis ST, Fein H. Topical treatment for non-melanoma skin cancer and precursor lesions. Semin Cutan Med Surg 2004 23 : 174 183.
13. Patel MJ, Stockfleth E. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment? Br J Dermatol 2007 156 : 53 6.
14. Green CL, Khavari PA. Targets for molecular therapy of skin cancer. Semin Cancer Biol 2004 14 : 63 9.
15. Taguchi M, Watanabe S, Yashima K et al. Aberrations of the tumour suppression p53 gene and p53 protein in solar keratosis in human skin. J Invest Dermatol 1994 103 : 500 503.
16. Ziegler A, Jonason AS, Leffell DJ et al. Sunburn and p53 in the onset of skin cancer. Nature 1994 372 : 773 776.
17. Brash DE, Ziegler A, Jonason A et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumour promotion. J Invest Dermatol Symp Proc 1996 1 : 136 142.
18. Kern WH, McCray MK. The histopathologic differentiation of keratoacanthoma and squamous cell carcinoma of the skin. J Cutan Pathol 1980 7 : 318 325.
19. Waring AJ, Takata M, Rehman I, Rees JL. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 1996 73 : 649 653.
20. Bogenhagen DF. Repair of mtDNA in vertebrates. Am J Hum Genet 1999 64 : 1276 1281.
21. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A 1988 85 : 6465 6467.
22. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res 2001 488 : 119 133.
23. Durham SE, Krishnan KJ, Betts J, Birch-Machin MA. Mitochondrial DNA damage in non-melanoma skin cancer. Br J Cancer 2000 88 : 90 5.
24. Prior SL, Griffiths AP, Baxter JM et al. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 2006 27 : 945 950.
25. Kim SH, Chi JG, Reith A, Kadenbach B. Quantitative analysis of mitochondrial DNA deletion in paraffin embedded muscle tissues from patients with KSS and CPEO. Biochem Biophys Acta 1997 1360 : 193 195.
26. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J Pathol 1994 172 : 1 4.
27. Brash DE, Rudolph JA, Simon JA et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991 88 : 10124 10128.
28. Suzuki M, Toyooka S, Miyajima K et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 2003 9 : 5636 5641.
29. Kumimoto H, Yamane Y, Nishimoto Y et al. Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer 2004 108 : 228 231.
30. Tully G, Barritt SM, Bender K et al. Results of a collaborative study of the EDNAP group regarding mitochondrial DNA heteroplasmy and segregation in hair shafts. Forensic Sci Int 2004 140 : 1 11.
31. Liu VWS, Shi HH, Cheung ANY et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 2001 61 : 5998 6001.
32. Zhao YB, Yang HY, Zhang XW, Chen GY. Mutation in D-loop region of mitochondrial DNA in gastric cancer and its significance. World J Gastroenterol 2005 11 : 3304 3306.
33. Lièvre A, Chapusot C, Bouvier AM et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 2005 23 : 3517 3525. (Pubitemid 46243496)
34. Baracca A, Sgarbi G, Mattiazzi M et al. Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. Biochim Biophys Acta 2007 1767 : 913 919.
35. Vives-Bauza C, Gonzalo R, Manfredi G et al. Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 2006 391 : 136 141.
36. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995 18 : 775 794.
37. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 1997 11 : 118 124.
38. Wikonkal NM, Brash DE. Ultraviolet radiation induced signature mutations in photocarcinogenesis. J Investig Dermatol Symp Proc 1999 4 : 6 10.
39. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signalling. J Biol Chem 2000 275 : 16202 16212.
40. Mihara M, Erster S, Zaika A et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003 11 : 577 590.
41. Erster S, Mihara M, Kim RH et al. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 2004 24 : 6728 6741.